scholarly journals Treatment of Helicobacter Pyori – an Overview of Current Strategies of Diagnostic and Treatment

2021 ◽  
Vol 28 (3) ◽  
pp. 263-267
Author(s):  
Ruxandra BABIUC ◽  
◽  
Raluca Anica IONESCU ◽  
Lucian NEGREANU ◽  
◽  
...  

Helicobacter Pylori infection, responsible for ulcerous disease, atrophic gastritis,gastric cancer and MALT lymphoma (mucosa-associated lymphoid tissue) has a very high prevalence in the general population (approximately 50%). In Romania there are few data related to the prevalence of Helicobacter Pylori infection, as well as the resistance to antibiotic treatment, and the methods of patient surveillance are limited by costs and low accessibility. The aim of our paper is to recall the current possibilities of treatment and supervision of this category of patients, taking into account that the appropiate treatment and good monitoring of the patient can cure the complications of the disease and may prevent the occurrence of malignancies.

2011 ◽  
Vol 20 (8) ◽  
pp. 1665-1672 ◽  
Author(s):  
Makoto Nakao ◽  
Keitaro Matsuo ◽  
Hidemi Ito ◽  
Kohei Shitara ◽  
Satoyo Hosono ◽  
...  

2007 ◽  
Vol 16 (4) ◽  
pp. 662-667 ◽  
Author(s):  
Catterina Ferreccio ◽  
Antonio Rollán ◽  
Paul R. Harris ◽  
Carolina Serrano ◽  
Alessandra Gederlini ◽  
...  

2010 ◽  
Vol 55 (11) ◽  
pp. 3132-3137 ◽  
Author(s):  
Shigeto Mizuno ◽  
Ikuya Miki ◽  
Tsukasa Ishida ◽  
Masaru Yoshida ◽  
Mitsuko Onoyama ◽  
...  

2011 ◽  
pp. 63-71
Author(s):  

Background: Intestinal metaplasia is a precancerous lesion. Helicobacter pylori is identified as an important cause of gastric cancer. This study is aimed at assessing the intestinal metaplasia and Helicobacter pylori infection and their relation in patients with chronic gastritis. Patients and methods: Study includes 75 patients with chronic gastritis diagnosed by clinical, endoscopic and histopathological criteria. Intestinal metaplasia is diagnosed by HE stain. Hp infection is tested by CLO-test from Viet A Ltd. Results: Hp infecton rate in this study is 66.67% and is highest in patients with antral gastritis. Intestinal metaplasia is found in 29.33% of patients with chronic gastritis with the predominance of complete intestinal metaplasia. The rate of intestinal metaplasia is the highest in the group with chronic atrophic gastritis. There is a significant relationship between intestinal metaplasia and Hp ìnfection. Conclusion: Hp and intestinal metaplasia are found at significant rates in chronic gastritis. The rate of intestinal metaplasia is clearly higher in the group with Hp-positive chronic gastritis.


Author(s):  
Beom Jin Kim

Atrophic gastritis (AG) and intestinal metaplasia (IM) are considered the main precursor lesions of gastric cancer, and the risk of gastric cancer in the gastric mucosa increases in the presence of AG and IM. The development of intestinal-type gastric adenocarcinoma represents the last step of an inflammation-metaplasia-dysplasia-carcinoma sequence, called the Correa cascade of multistep gastric carcinogenesis. The incidences of both AG and IM tend to increase with age. <i>Helicobacter pylori</i> is regarded the most important factor in the development of IM; the progression of AG to IM is also affected by numerous environmental factors and individual genetic factors. Therefore, understanding the natural course of AG and IM is very important, especially in areas with a high prevalence of gastric cancer such as Korea.


Sign in / Sign up

Export Citation Format

Share Document